EU-Authorized PAA Biocides: What Manufacturers and Distributors Must Do

Key data

Manufacturers and distributors of peracetic acid-based biocidal disinfectants have had a new unified regulatory framework since 3 November 2026 to operate across the EU. The Commission Implementing Regulation (EU) 2026/2406 grants Union authorization for the «PAA based disinfectants - BPF2» family, which simplifies access to the European market but imposes strict conditions that must be met to avoid product withdrawal and sanctions.

Until now, marketing these products in different EU countries required obtaining national authorizations in each Member State, with the associated administrative costs and timelines. This Union authorization changes that logic: a single title enables marketing throughout the internal market, but in exchange for complying with the conditions established in the authorization uniformly across all countries.

What does this regulation establish?

The regulation grants a Union authorization for the biocide family called «PAA based disinfectants - BPF2», whose main active substance is peracetic acid. This authorization is granted under the Regulation (EU) No 528/2012, which regulates the marketing and use of biocides in the European Union.

The key elements established by the regulation are:

• Single pan-European authorization: Holders can market BPF2 family products in all Member States without filing additional national authorizations.
• Applications regulated by product type: Authorized uses are limited to specific disinfection applications regulated by the corresponding product type, according to the classification in Regulation (EU) 528/2012.
• Labeling obligations: Products must be labeled in accordance with the conditions established in the authorization, with no room for unilateral adaptations by manufacturers or distributors.
• Use restrictions: There are use restrictions that must be respected throughout the chain: manufacturer, distributor, and end professional user.
• Risk management measures: The authorization includes specific risk management measures that must be implemented to maintain the validity of the authorization.
• Consequences of non-compliance: Failure to comply with any of these conditions may result in market withdrawal of affected products and the imposition of administrative sanctions.

Economic and operational impact

This authorization has a dual impact for companies in the sector:

Efficiency opportunity: The single authorization eliminates the need to file and maintain national authorizations in each Member State where the company wants to operate. For companies already distributing in several EU countries, this means a direct reduction in administrative and legal costs, as well as a simplification of regulatory management.

Adaptation cost: In exchange, companies must review and adapt their processes to comply uniformly with the authorization conditions across all markets. This particularly affects:

• Review and updating of labeling for all BPF2 family products.
• Updating of internal procedures to respect authorized use restrictions.
• Implementation of required risk management measures.
• Training of sales teams and professional users on the new conditions.

Non-compliance risk: The regulation is explicit: non-compliance may result in market withdrawal of products and administrative sanctions. For companies with significant sales volume in this segment, the economic impact of market withdrawal can be very significant.

Who does it affect?

• Manufacturers of peracetic acid-based biocidal disinfectants that market or intend to market products from the «PAA based disinfectants - BPF2» family in the EU.
• Distributors of these products in any Member State of the European Union.
• Professional users who use these biocides in their processes (food industry, healthcare, agriculture, water treatment, etc.).
• Regulatory and compliance officers (Regulatory Affairs) of companies in the chemical and industrial hygiene sectors.
• Legal advisors and consultants who assist companies in complying with Regulation (EU) 528/2012.

Practical example

Imagine a Spanish company manufacturing industrial disinfectants that markets peracetic acid-based products in Spain, France, Germany, and Italy. Until now, it had to maintain four separate national authorizations, with their respective renewal processes, country-specific labeling adaptations, and differentiated regulatory costs.

With the Union authorization for «PAA based disinfectants - BPF2», this company can operate with a single title in all four markets. However, it must act immediately: verify that the labeling of all its BPF2 family products complies exactly with the conditions of the new authorization, verify that the uses it promotes align with the applications authorized for the corresponding product type, and implement the required risk management measures. If it markets products outside the authorized conditions, it risks market withdrawal in all Member States simultaneously, not just one.

What should companies do now?

1. Identify if your products belong to the BPF2 family: Verify whether the peracetic acid-based disinfectants you manufacture or distribute are covered by the «PAA based disinfectants - BPF2» authorization of Regulation (EU) 2026/2406.
2. Review current labeling: Compare the current labeling of your products with the conditions established in the Union authorization and identify any deviations that need to be corrected.
3. Audit use restrictions: Review that the uses for which you market and promote these products strictly comply with the applications authorized for the corresponding product type.
4. Implement risk management measures: Ensure that internal procedures and technical documentation reflect the risk management measures required in the authorization.
5. Inform professional users: Communicate the authorized use conditions to your professional customers to prevent non-compliant uses that could generate liability in the distribution chain.
6. Consult a biocides specialist: If you have doubts about the scope of the authorization or specific obligations, seek advice from an expert in biocides regulation under Regulation (EU) 528/2012 before any inspection or claim occurs.

Official source

Consult complete regulation at official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602406